ask="1.470"
ask_size="1300"
average_daily_volume="1159020"
bid="0.930"
bid_size="1000"
book_value="0.606"
change="-0.009"
change_from_200_day_moving_average="-1.940"
change_from_50_day_moving_average="-0.034"
change_from_52_week_high="-3.999"
change_From_52_week_low="0.431"
change_in_percent="-0.957%"
close="0.931"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.237"
ebitda="-8.78M"
eps_estimate_current_year="-1.120"
eps_estimate_next_quarter="-0.250"
eps_estimate_next_year="0.190"
ex_dividend_date="N/A"
float_shares="7029000"
high="1.020"
high_52_weeks="4.930"
last_trade_date="1/6/2017"
last_trade_price="0.931"
last_trade_size="100"
last_trade_time="3:59pm"
low="0.929"
low_52_weeks="0.500"
market_capitalization="6.65M"
moving_average_200_day="2.871"
moving_average_50_day="0.965"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.330"
open="0.950"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-67.571%"
percent_change_from_50_day_moving_average="-3.508%"
percent_change_from_52_week_high="-81.115%"
percent_change_from_52_week_low="+86.200%"
previous_close="0.940"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="4.900"
price_per_book="1.551"
price_per_sales="2.626"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="0.220"
stock_exchange="NCM"
symbol="OPXA"
volume="575094"
weeks_range_52="0.500 - 4.930"
